id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-297368-ju6r1rf1	Moradi, Soroush	Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs	2020-10-31		.txt	text/plain	2924	133	50	In a cross-sectional study, all RPs with an updated medical record between December 1, 2019, and February 29, 2020, at the rheumatology clinic of Shahid Beheshti Hospital, Qom, Iran were included (as the case group), and the prevalence of COVID-19 was compared to the paired control group—individuals without RDs, randomly selected from the Qom Health Network's database. The current study aims to firstly evaluate the prevalence of COVID-19 in RPs and compare it to the prevalence of SARS-CoV-2 infection in a group of paired individuals without any past medical history of RDs, immunodeficiencies, or immunosuppressive therapies and second, to evaluate the potential role of DMARDs in RPs against the COVID-19. Besides, individuals residing under the Qom Health Network coverage, without a past medical history of RDs, were randomly selected as the control group based on inclusion and exclusion criteria mentioned later in the manuscript.	./cache/cord-297368-ju6r1rf1.txt	./txt/cord-297368-ju6r1rf1.txt